CColumbus Venture Partners
Columbus Venture Partners is a Valencia-based venture capital firm specialising in life sciences, founded in 2016 and registered with the CNMV as an SGEIC. It invests in therapeutic and industrial biotechnology, advanced therapies, medical devices, precision medicine, diagnostics and digital health across Europe and the US, often co-founding and building the companies it backs, from Series A and B through growth rounds, with minimum tickets of €2M. It has raised Columbus Life Science Funds I (2016), II (over €70M, 2019), III (€120M, 2021) and IV (€150M, 2023), and in 2026 launched Fund V with a €200M target, backed by up to €70M from CDTI Innovación through Innvierte. Notable exits include Viralgen and AskBio, Sanifit Therapeutics and Radioterapia de Protones, and recent investments include Alto Pharmacy, Curve Therapeutics and Sermes CRO.
Team
Portfolio companies 16
Open 12 as list → On map →
O
A
H
I
D
M
C
Q
M
A
T
T
A
S
S